An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA-Reference-Cited by-同舟云学术

An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA

Published:2010-09-10 Issue:1 Volume:70 Page:54-59
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Isenberg D. A.,Allen E.,Farewell V.,D'Cruz D.,Alarcon G. S.,Aranow C.,Bruce I. N.,Dooley M. A.,Fortin P. R.,Ginzler E. M.,Gladman D. D.,Hanly J. G.,Inanc M.,Kalunian K.,Khamashta M.,Merrill J. T.,Nived O.,Petri M.,Ramsey-Goldman R.,Sturfelt G.,Urowitz M.,Wallace D. J.,Gordon C.,Rahman A.

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical markers, metrics, indices, and clinical trials;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Flare in Systemic Lupus Erythematosus: Lost in Translation?;The Journal of Rheumatology;2024-03-01

3. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study;Annals of the Rheumatic Diseases;2024-02-29

5. The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study;Rheumatology;2023-07-17